Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Infographic | 2023
Youth, Mortality, About PWUD, Transitions in care/treatment, Substitution/OAT
Report | 2023
Youth, Mortality, Transitions in care/treatment, Substitution/OAT, About PWUD
This rapid review aimed to synthesize available evidence on CBD as a potential harm reduction tool for people who use drugs while providing clinical and research insights.
Lit review | 2023
Harm reduction
This scoping review broadly aimed to map the literature on social vulnerability indices (SVIs).
Scoping review | 2023
Equity, Poverty
Accidental overdoses are now the leading cause of death among people with HIV (PWH) in British Columbia (BC). We examined the utilization and retention of opioid agonist therapy (OAT).
Original research | 2023
Substitution/OAT, About PWUD, Outcomes
The aim of this analysis was to explore the impact of safer supply programs on injection practices from the perspective of clients and providers in Ontario, Canada.
Original research | 2023
Injecting drugs, Evidence base, Safer supply, About PWUD, About prescribers
The aim of this scoping review is to explore nurse prescribing practices for medication-assisted treatment of opioid use disorder (MOUD) globally with a view to informing equitable access and polic
Scoping review | 2023
About prescribers, Policy/Regulatory
To explore the beliefs, values and perceptions of people who use substances (PWUS) around using and accessing virtual overdose monitoring services (VOMS) in Canada.
Original research | 2023
About PWUD, Digital health, Overdose, SCS/OPS
We explored patient perceptions of incorporating harm reduction supplies and education in hospital care with patients with opioid use disorder (OUD).
Original research | 2023
Harm reduction, Hospitals, About PWUD
This project explores the lived experiences of persons who were in recovery from opioid use disorder (OUD) or a family member of someone with OUD with a focus on stigma.
Original research | 2023
Stigma, About PWUD
There is a gap in literature on the impact of opium tincture (OT) on patients’ quality of life (QoL) compared to standard treatment options such as methadone.
Original research | 2023
Safer supply, Substitution/OAT, Sex/Gender , Outcomes
This study examined the perceived impacts of Ballot Measure 110, which decriminalized noncommercial possession of drugs that are illegal under the Controlled Substances Act, on law enforcement and
Original research | 2023
Legal system/law enforcement, Decriminalization/legalization, Policy/Regulatory
There are growing efforts to implement integrated programs offering harm reduction services alongside other services for people who use drugs.
Original research | 2023
Harm reduction, Wrap-around services
This study explores the role of Overdose Prevention Sites (OPS) within the geographies of survival of vulnerably housed people who use drugs (PWUD).
Original research | 2023
SCS/OPS
Report | 2023
Overdose, Clinical guidance, Workplace
Guidelines | 2023
Clinical guidance, Substitution/OAT
Guide | 2023
les guides de pratique clinique, à propos des prescripteurs, à propos des pharmaciens, la surdose, la mortalité, la politique / le cadre de réglementation
We use national surveillance data to evaluate race/ethnicity by sex/gender differences and trends in substance use treatment admissions and overdose deaths involving opioid and stimulant use.
Original research | 2023
Overdose, Mortality, Illegal drugs, Stimulants, Equity
In this study, fentanyl immunoassay strips were evaluated for use as a secondary test for fentanyl, including for the testing of alternative matrices, such as powders, e-liquids, and infused papers
Original research | 2023
Drug checking
